Literature DB >> 24308970

The guanine nucleotide exchange factor Tiam1: a Janus-faced molecule in cellular signaling.

P Boissier1, U Huynh-Do2.   

Abstract

The Rho family of GTPases consists of several small proteins that have been described as molecular switches, playing important roles in a wide variety of fundamental cellular processes and in human diseases such as cancer. These proteins, active in the GTP conformation and inactive in the GDP form, are in turn regulated by guanine nucleotide exchange factors (GEFs), guanine nucleotide activating proteins (GAPs) and guanine dissociation inhibitors (GDIs). Two decades ago, Tiam1 (T-lymphoma invasion and metastasis) was identified as a GEF specific for Rac1 activation, but also for Cdc42 and in a lesser extent RhoA. Acting principally upstream of Rac1, Tiam1 is mainly involved in the regulation of Rac1 mediated signaling pathways including cytoskeletal activities, cell polarity, endocytosis and membrane trafficking, cell migration, adhesion and invasion, cell growth and survival, metastasis and carcinogenesis. However, given the large number of protein interaction domains found in its structure, it is possible that Tiam1 affects cellular processes in another way than through its GEF activity by interactions with other signaling proteins. Due to its functional diversity, Tiam1 is involved in multiple steps of tumorigenesis. As its name suggests, Tiam1 has been shown to increase T-cell lymphoma invasion and metastasis. It also promotes migration of fibroblasts, neuronal and cancer cells. On the contrary, Tiam1-induced cell adhesion has also been described, as opposed to cell migration. Moreover, studies indicate that Tiam1 is involved in both anti-apoptotic and pro-apoptotic mechanisms. While increasing evidence has demonstrated Tiam1's contribution to tumorigenesis and metastasis, others suggest that Tiam1 could have anti-cancer properties. In the present review, we discuss the current knowledge about the controversial roles of Tiam1 in cellular signaling. In particular, we will focus on Tiam1's regulation, its biological functions and implication in cancer.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DH; Dbl homology; GAP; GDI; GDP; GEF; GTP; GTPase-activating protein; Guanine nucleotide exchange factors; JIP/IB2; PH; RBD; Rac1; Ras binding domain; Rho-GTPases; STEF; Sif and Tiam1-like exchange factor; Signaling; T-lymphoma invasion and metastasis; Tiam1; Tumorigenesis; c-Jun N-terminal kinase-interacting protein/islet-brain 2; guanine dissociation inhibitor; guanine nucleotide-exchange factor; guanosine diphosphate; guanosine triphosphate; pleckstrin homology

Mesh:

Substances:

Year:  2013        PMID: 24308970     DOI: 10.1016/j.cellsig.2013.11.034

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  43 in total

1.  The Rac-GEF Tiam1 Promotes Dendrite and Synapse Stabilization of Dentate Granule Cells and Restricts Hippocampal-Dependent Memory Functions.

Authors:  Jinxuan Cheng; Federico Scala; Francisco A Blanco; Sanyong Niu; Karen Firozi; Laura Keehan; Shalaka Mulherkar; Emmanouil Froudarakis; Lingyong Li; Joseph G Duman; Xiaolong Jiang; Kimberley F Tolias
Journal:  J Neurosci       Date:  2020-12-16       Impact factor: 6.167

2.  Opposite functions of STAT3 and Smad3 in regulating Tiam1 expression in Th17 cells.

Authors:  Thomas Buttrick; Samia J Khoury; Wassim Elyaman
Journal:  Small GTPases       Date:  2017-09-18

3.  A Transformation-Defective Polyomavirus Middle T Antigen with a Novel Defect in PI3 Kinase Signaling.

Authors:  Deborah Denis; Cecile Rouleau; Brian S Schaffhausen
Journal:  J Virol       Date:  2017-01-03       Impact factor: 5.103

4.  Lamellipodia are crucial for haptotactic sensing and response.

Authors:  Samantha J King; Sreeja B Asokan; Elizabeth M Haynes; Seth P Zimmerman; Jeremy D Rotty; James G Alb; Alicia Tagliatela; Devon R Blake; Irina P Lebedeva; Daniel Marston; Heath E Johnson; Maddy Parsons; Norman E Sharpless; Brian Kuhlman; Jason M Haugh; James E Bear
Journal:  J Cell Sci       Date:  2016-05-12       Impact factor: 5.285

5.  The N-terminal domain of the adaptor protein p140Cap interacts with Tiam1 and controls Tiam1/Rac1 axis.

Authors:  Jennifer Chapelle; Annalisa Baudino; Federico Torelli; Aurora Savino; Alessandro Morellato; Costanza Angelini; Vincenzo Salemme; Giorgia Centonze; Dora Natalini; Marta Gai; Valeria Poli; Thilo Kähne; Emilia Turco; Paola Defilippi
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

6.  Clinical implication of Tiam1 overexpression in the prognosis of patients with serous ovarian carcinoma.

Authors:  Huiwen Li; Xuelian Cui; Dingbao Chen; Yang Yang; Junjie Piao; Zhenhua Lin; Guanghai Yan; Danhua Shen
Journal:  Oncol Lett       Date:  2016-09-05       Impact factor: 2.967

7.  Rac1 mediates cadherin-11 induced cellular pathogenic processes in aortic valve calcification.

Authors:  Kiran A Vaidya; Matthew P Donnelly; Ablajan Mahmut; Jae Woong Jang; Terence W Gee; Marine-Ayan Ibrahim Aibo; Robert Bossong; Clare Hall; Sanjay Samb; Jonathan Chen; Jonathan T Butcher
Journal:  Cardiovasc Pathol       Date:  2022-01-21       Impact factor: 2.185

8.  The Tiam1 guanine nucleotide exchange factor is auto-inhibited by its pleckstrin homology coiled-coil extension domain.

Authors:  Zhen Xu; Lokesh Gakhar; Fletcher E Bain; Maria Spies; Ernesto J Fuentes
Journal:  J Biol Chem       Date:  2017-09-07       Impact factor: 5.157

9.  Altered expression of TIAM1 in endotoxin-challenged airway epithelial cells and rodent septic models.

Authors:  Jie Ma; Chuanxi Chen; Yongjun Liu; Mahendra Damarla; Becky M Vonakis; Xiangdong Guan; Li Gao
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

10.  Semaphorin3F Drives Dendritic Spine Pruning Through Rho-GTPase Signaling.

Authors:  Bryce W Duncan; Vishwa Mohan; Sarah D Wade; Young Truong; Alexander Kampov-Polevoi; Brenda R Temple; Patricia F Maness
Journal:  Mol Neurobiol       Date:  2021-04-15       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.